Browse diseases

…(SLE), rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS)—in Brazil’s public and private healthcare systems from 201…

…Objectives To investigate whether systemic lupus erythematosus (SLE) increases the risk of cataract development and to evaluat…

…l JT, et al. Deucravacitinib, a tyrosine kinase 2 inhibitor, in systemic lupus erythematosus: a phase II, randomized, double-blind, placebo-controlled trial…

…s, suggesting ICIs may constitute a novel class of drug-induced SLE triggers. Personalised long-term safety monitoring for ICIs is …

…Objectives To evaluate whether patients with systemic lupus erythematosus (SLE) have different nailfold videocapillaroscopy (NVC) finding…

…lic events (TE) and antiphospholipid syndrome (APS) relative to systemic lupus erythematosus (SLE) onset and assess relationships between TE, APS and anti-p…

…P-1 RAs may provide metabolic and anti-inflammatory benefits in SLE with an acceptable safety profile; however, clinical data speci…

…finalised LBFSS was validated (step 5) in a large international SLE cohort. Psychometric evaluation included internal consistency, …

…Introduction Systemic sclerosis(SSc) and systemic lupus erythematosus(SLE) are distinct connect…

…Background Systemic lupus erythematosus (SLE) shows marked heterogeneity in epidemiology across regions…

…yielded the highest LR+ (33.7) and lowest LR– (0.3). Within the SLE cohort, the MAP index showed higher sensitivity than anti-dsDNA…

…Background The diagnosis of systemic lupus erythematosus (SLE) is clinically complex, and early identification is essent…